Eluxadoline-induced Recurrent Pancreatitis in a Young Female without a Gallbladder: A Case Report and Literature Review

Eluxadoline is a mixed opioid receptor agonist and antagonist approved for the treatment of diarrhea-predominant irritable bowel syndrome (IBS). It is believed to decrease visceral hypersensitivity without completely inhibiting intestinal motility. Pooled safety data from two phase three randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Khetpal, Neelam, Yadav, Lokesh, Khalid, Sameen, Kumar, Ranjeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389028/
https://www.ncbi.nlm.nih.gov/pubmed/30820368
http://dx.doi.org/10.7759/cureus.3747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389028/
https://www.ncbi.nlm.nih.gov/pubmed/30820368
http://dx.doi.org/10.7759/cureus.3747

Ejemplares similares